With a consistent decline in share price and EPS, BGI Genomi...
With a consistent decline in share price and EPS, BGI Genomics' investor sentiment is negative. Market likely factored in falling EPS with a high PE ratio at 79.62. Despite 'buy when blood's on the streets' philosophy, investors should consider the company's 3 warning signs, of which 2 are serious.
![](https://pubimg-10000538.picsh.myqcloud.com/202205090000031596276539dbb.jpg)
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment